Randomised controlled trial of hydroquinine in muscle cramps

Lancet

Volumn 349, Issue 9051, 1997, Pages 528-532

  Jansen, P H P ^a   Veenhuizen, K C W ^b   Wesseling, A I M ^c   De Boo, Th ^b   Verbeek, A L M ^b  

^a Ziekenhuls Gelderse Vallei ^*  (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c Med Department of ASTA Medica B V   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROQUININE; PLACEBO; QUININE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0031051046     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)80085-2     Document Type: Article

References (21)

1. Jansen PHP, van Dijck JAAM, Verbeek ALM, et al. Estimation of the frequency of muscle cramp in the adult population of the Netherlands: a neuro-epidemiologic survey. In: Layzer RB, ed. Motor unit hyperactivity states. New York: Raven Press, 1993: 125-31.
2. Ketz E. Leitsymptom Muskel- und Wadenkrämpfe aus neurologisher Sicht. In: Mörl H, ed. Muskelkrämpfe. Berlin: Springer, 1987: 59-66.
3. Naylor JR, Young JB. A general population survey of rest cramps. Age Ageing 1994; 23: 418-20.
4. Jansen PHP, Joosten EMG, Vingerhoets HM. Muscle cramp; main theories as to aetiology. Eur Arch Psychiatry Neurol Sci 1990; 239: 337-12.
5. Layzer RB. The origin of muscle fasciculations and cramps. Muscle Nerve 1994; 17: 1243-49.
6. Harats N. Quinine-related hypoglycemia. N Engl J Med 1984; 310: 1331.
7. Boland ME. Complications of quinine poisoning. Lancet 1985; i: 384-85.
8. Ljunggren B. Phototoxic properties of quinine and quinidine: two quinoline methanol isomers. Photodermatol Photoimmunol Photomed 1988; 5: 133-38.
9. Barr E, Douglas JF, Hill CM. Recurrent acute hypersensitivity to quinine. BMJ 1990; 301: 323.
10. Punukollu RC. Quinine hepatotoxicity: an underrecognized or rare phenomenon? Arch Intern Med 1990; 150: 1112-13.
11. Jansen PHP, Joosten EMG, Vingerhoets HM. Clinical diagnosis of muscle cramp and muscular cramp syndromes. Eur Arch Psychiatry Clin Neurosci 1991; 241: 98-101.
12. Simchak AC., Pascuzzi RM. Muscle cramps. Seminars Neurol 1991; 11: 281-87.
13. Jansen PHP, Veenhuizen KCW, Verbeek ALM, et al. Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. J Neurol Sci 1994; 122: 157-61.
14. Dunn NR. Effectiveness of quinine for night cramps. Br J Gen Pract 1993; 3: 127-28.
15. Hing M, Wells G. Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ 1995; 310: 13-17.
16. Dunn NR, Campell M. Study quoted had flamed design. LBMJ 1995; 310: 1136.
17. Egger M, Davey Smith G. Misleading meta-analysis. BMJ 1995; 310: 752-54.
18. Görlich HD, v Gablenz E, Steinberg HW. Behandlung rezidivierender nächtlicher wadenkrämpfe. Arzneimittelforschung 1991; 41: 167-75.
19. Connolly PS, Shirley EA, Wasson JH, Nierenberg DW. Treatment of nocturnal leg cramps: a cross over trial of quinine DS vitamin E. Arch Intern Med 1992; 152: 1877-80.
20. Fung MC, Holbrook JH. Placebo-controlled trial of quinine therapy for nocturnal leg cramps. West J Med 1989; 151: 42-44.
21. De Vries HA. Quantitative electromyographic investigation of the spasm theory of muscle pain. Am J Phys Med Rehabil 1966; 45: 119-34.